Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues

被引:150
作者
Yokoo, T
Ohashi, T
Shen, JS
Sakurai, K
Miyazaki, Y
Utsunomiya, Y
Takahashi, M
Terada, Y
Eto, Y
Kawamura, T
Osumi, N
Hosoya, T
机构
[1] Jikei Univ, Sch Med, Dept Internal Med & Gene Therapy, Minato Ku, Tokyo 1058461, Japan
[2] Jikei Univ, Sch Med, Dept Pediat, Minato Ku, Tokyo 1058461, Japan
[3] Jikei Univ, Sch Med, Inst DNA Med, Minato Ku, Tokyo 1058461, Japan
[4] Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Aoba Ku, Sendai, Miyagi 9808575, Japan
[5] Tokyo Med & Dent Univ, Dept Homeostasis Med & Nephrol, Bunkyo Ku, Tokyo 1138519, Japan
关键词
organogenesis; regeneration;
D O I
10.1073/pnas.0406878102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The use of stem cells has enabled the successful generation of simple organs. However, anatomically complicated organs such as the kidney have proven more refractory to stem-cell-based regenerative techniques. Given the limits of allogenic organ transplantation, an ultimate therapeutic solution is to establish self-organs from autologous stem cells and transplant them as syngrafts back into donor patients. To this end, we have striven to establish an in vitro organ factory to build up complex organ structures from autologous adult stem cells by using the kidney as a target organ. Cultivation of human mesenchymal stem cells in growing rodent embryos enables their differentiation within a spatially and temporally appropriate developmental milieu, facilitating the first step of nephrogenesis. We show that a combination of whole-embryo culture, followed by organ culture, encourages exogenous human mesenchymal stem cells to differentiate and contribute to functional complex structures of the new kidney.
引用
收藏
页码:3296 / 3300
页数:5
相关论文
共 24 条
[21]  
2-9
[22]   Gene delivery using human cord blood-derived CD34+ cells into inflamed glomeruli in NOD/SCID mice [J].
Yokoo, T ;
Ohashi, T ;
Utsunomiya, Y ;
Okamoto, A ;
Suzuki, T ;
Shen, JS ;
Tanaka, T ;
Kawamura, T ;
Hosoya, T .
KIDNEY INTERNATIONAL, 2003, 64 (01) :102-109
[23]   Genetically modified bone marrow continuously supplies anti-inflammatory cells and suppresses renal injury in mouse Goodpasture syndrome [J].
Yokoo, T ;
Ohashi, T ;
Utsunomiya, Y ;
Shen, JS ;
Hisada, Y ;
Eto, Y ;
Kawamura, T ;
Hosoya, T .
BLOOD, 2001, 98 (01) :57-64
[24]  
Yokoo T, 2001, J AM SOC NEPHROL, V12, P2330, DOI 10.1681/ASN.V12112330